Rule · OFAC · 23 Sep 2026 · 2026-19423
General License 2 authorizes transactions otherwise prohibited by the Democratic Republic of the Congo Sanctions Regulations (31 CFR part 547) that are ordinarily incident and necessary to exporting agricultural commodities, medicine, medical devices, replacement parts, software updates, or conducting clinical trials to the Democratic Republic of the Congo or Rwanda. The license defines agricultural commodities, medicine, and medical devices according to specific federal statutes and includes transactions ordinarily incident to medical care and clinic operations. It does not authorize any other transactions prohibited by the regulations unless separately authorized.
DEPARTMENT OF THE TREASURY Office of Foreign Assets Control 31 CFR Part 547 Publication of the Democratic Republic of the Congo Sanctions Regulations Web General License 2 AGENCY: Office of Foreign Assets Control, Treasury. ACTION: Publication of a web general license. SUMMARY: The Department of the Treasury’s Office of Foreign Assets Control (OFAC) is publishing a general license (GL) issued pursuant to the Democratic Republic of the Congo Sanctions Regulations: GL 2. This GL was previously made available on OFAC’s website. DATES: GL 2 was issued on July 10,
2026. See SUPPLEMENTARY INFORMATION
for additional relevant dates. FOR FURTHER INFORMATION CONTACT:
OFAC: Assistant Director for Regulatory Affairs, 202–622–4855; or https:// ofac.treasury.gov/contact-ofac. SUPPLEMENTARY INFORMATION:
Electronic Availability This document and additional information concerning OFAC are available on OFAC’s website: https:// ofac.treasury.gov/. Background On July 10, 2026, OFAC issued GL 2 to authorize certain transactions otherwise prohibited by the Democratic Republic of the Congo Sanctions Regulations, 31 CFR part 547. GL 2 was made available on OFAC’s website (https://ofac.treasury.gov) when it was issued. The text of this GL is provided below. OFFICE OF FOREIGN ASSETS CONTROL Democratic Republic of the Congo Sanctions Regulations 31 CFR Part 547 GENERAL LICENSE NO. 2 Authorizing Transactions Related to Agricultural Commodities, Medicine, Medical Devices, Replacement Parts and Components, Software Updates, or Clinical Trials (a) Except as provided in paragraph (c) of this general license, all transactions prohibited by the Democratic Republic of the Congo Sanctions Regulations, 31 CFR part 547 (DRCSR), that are ordinarily incident and necessary to: (1) the exportation or reexportation of agricultural commodities, medicine, medical devices, replacement parts and components for medical devices, or software updates for medical devices to the Democratic Republic of the Congo (DRC) or the Republic of Rwanda (Rwanda), or to persons in third countries purchasing specifically for provision to the DRC or Rwanda; (2) the prevention, diagnosis, or treatment of any disease or medical condition in the DRC or Rwanda; or (3) the conduct of clinical trials and other medical research activities in the DRC or Rwanda are authorized. (b) For the purposes of this general license, agricultural commodities,
medicine, and medical devices are defined as follows:
(1) Agricultural commodities.
Agricultural commodities are products that fall within the term ‘‘agricultural commodity’’ as defined in section 102 of the Agricultural Trade Act of 1978 (7 U.S.C. 5602) and are intended for use as:
(i) Food for humans (including raw, processed, and packaged foods; live animals; vitamins and minerals; food additives or supplements; and bottled drinking water) or animals (including animal feeds); (ii) Seeds for food crops; (iii) Fertilizers or organic fertilizers; or (iv) Reproductive materials (such as live animals, fertilized eggs, embryos, and semen) for the production of food animals. (2) Medicine. Medicine is an item that falls within the definition of the term ‘‘drug’’ in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321). (3) Medical devices. A medical device is an item that falls within the definition of ‘‘device’’ in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321). (c) This general license does not authorize any transaction otherwise prohibited by the DRCSR, unless separately authorized. Note 1 to General License No. 2. Nothing in this general license relieves any person from compliance with any other Federal laws or requirements of other Federal agencies. Note 2 to General License No. 2. The authorizations in this general license include all transactions ordinarily incident to the provision of medical care and the operation of medical clinics or facilities. Lisa M. Palluconi, Deputy Director, Office of Foreign Assets Control. Dated: July 10, 2026. Bradley T. Smith, Director, Office of Foreign Assets Control. [FR Doc. 2026–19423 Filed 9–22–26; 8:45 am] BILLING CODE 4810–AL–P
Note from RegAlert. AI assistants can read this document in full, and search 70,000+ more, through the RegAlert MCP connector (https://mcp.regalert.today/mcp). Free with an account. How to connect ChatGPT, Claude or Cursor.
More like this from OFAC
OFAC published 23 documents in the last 30 days. We email you each new one the day it's published.
Source: Office of Foreign Assets Control — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works
In RegAlert: added · updated